GE Healthcare named Gene Cartwright as president of its Molecular Diagnostics business to lead the development of the in vitro clinical diagnostics business.
He will be based in Piscataway, NJ.
Cartwright was previously at Abbott Laboratories as vice-president of strategic programs for its molecular diagnostics business. He received his PhD in chemistry from Stanford University.
Kenneth Buetow has been appointed to the new position of associate director for bioinformatics and information technologies at the National Cancer Institute, according to a recent NCI Cancer Bulletin.
Buetow was previously director of the NCI Center for Bioinformatics. In his new position, Buetow will "manage and execute information technology and bioinformatics initiatives that will lead to the usage of common tools, standards, and datasets across NCI; assist internal teams in adopting and leveraging NCI's cancer Biomedical Informatics Grid (caBIG) infrastructure; review and update NCI's existing and planned bioinformatics programs and activities; make recommendations for the creation of a standing group that will provide technical guidance on new projects; and regularly report to the NCI Executive Committee, of which he is a member," the Cancer Bulletin said.
NOTE: This is the last issue of
Cell-Based Assay News to be published
in 2005. We will resume our normal
publishing schedule on Jan. 9, 2006.